 Home > Biochemistry News > Biotechnology News > A seven-year controlled study shows that two Alzheimer's disease test drugs are not as effective as expected

A seven-year controlled study shows that two Alzheimer's disease test drugs are not as effective as expected

 Last Update: 2021-08-09
 Source: Internet
 Author: User

Tags

circle drug test

biological medicine

fail drug test drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Alzheimer's disease drugs have always been the "hardest bone" in the field, and the recent reports of the two drugs that have received much attention still seem to be unsatisfactory

Dominant hereditary Alzheimer’s disease is a rare form of Alzheimer’s disease (AD).

A team composed of Washington University School of Medicine and other institutions allowed 144 DIAD patients to receive "gantenerumab" or "solanezumab" or placebo treatment for a 7-year controlled study

Although no cognitive improvement or clinical benefit can be observed at this stage, many biological characteristics of AD patients in the "gantenerumab" group were significantly reduced, indicating that early treatment of DIAD still has potential benefits

The research team finally stated that the trial indicated the need for more optimized and more sensitive cognitive measurement of asymptomatic patients, and use of higher doses for a longer period of time to increase the effect of drugs and targets

These two drugs have always received considerable attention

As for another drug, "solanezumab", the US pharmaceutical giant Eli Lilly said in 2016 that it was very disappointed with the results of the drug's phase III clinical trial.

Editor-in-chief

This is disappointing news

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.